Total planned funding: $483,138,517
Clear active filters
University
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Mozambique | $61,219,671 |
| Malawi | $54,984,509 |
| Zimbabwe | $52,602,863 |
| Zambia | $39,779,960 |
| Kenya | $35,305,002 |
| Tanzania | $34,215,008 |
| Uganda | $26,090,847 |
| Lesotho | $21,541,277 |
| South Sudan | $19,049,079 |
| Botswana | $16,400,576 |
| Ethiopia | $13,639,513 |
| Democratic Republic of the Congo | $12,000,000 |
| South Africa | $11,932,229 |
| Eswatini | $11,040,256 |
| Asia Regional Program | $10,579,615 |
| Côte d'Ivoire | $10,214,345 |
| Nigeria | $9,605,482 |
| Western Hemisphere Region | $9,559,127 |
| Namibia | $8,500,000 |
| Angola | $6,329,195 |
| enumerations.Sierra Leone | $3,442,000 |
| Rwanda | $3,229,202 |
| Burundi | $3,221,309 |
| Cameroon | $2,600,150 |
| Ukraine | $2,439,234 |
| Vietnam | $2,013,068 |
| enumerations.Philippines | $1,605,000 |
Organizational Types
| University | $483,138,517 |
Program Areas
| Treatment | $225,249,658 |
| Prevention | $102,861,206 |
| Care | $61,523,095 |
| Governance and Systems | $52,792,618 |
| Testing | $39,737,664 |
| Management and Operations | $974,276 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $219,543,642 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $47,793,668 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $42,089,953 |
| HVCT: Testing: HIV Testing and Counseling | $39,737,664 |
| HVSI: Strategic Information | $31,453,078 |
| HKID: Care: Orphans and Vulnerable Children | $28,850,019 |
| HBHC: Care: Adult Care and Support | $14,819,754 |
| OHSS: Health Systems Strengthening | $11,210,611 |
| HLAB: Laboratory Infrastructure | $10,128,929 |
| HVTB: Care: TB/HIV | $10,082,846 |
| PDCS: Care: Pediatric Care and Support | $7,770,476 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $6,253,131 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $5,846,459 |
| PDTX: Treatment: Pediatric Treatment | $5,447,342 |
| HVMS: Management and Operations | $974,276 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $832,186 |
| HTXD: Treatment: ARV Drugs | $258,674 |
| HMBL: Biomedical Prevention: Blood Safety | $45,809 |